Tuhura Biosciences, Inc. (HURA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Tuhura Biosciences, Inc. on November 25, 2025, reporting an event that occurred on November 22, 2025. The Company is incorporated in Nevada and its common stock trades on The Nasdaq Capital Market under the symbol "HURA."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a regulatory disclosure regarding securities registration rather than financial performance results.
Material Changes
The primary material change reported is the effectiveness of the Company's Registration Statement on Form S-3 (File No. 333-291239), referred to as the "Shelf Registration Statement," which became effective on November 22, 2025. Consequently, the previously effective Resale Registration Statement (File No. 333-289532) regarding the resale of up to 9,321,545 shares of common stock (comprising 4,570,629 shares and 4,750,916 shares issuable upon warrant exercise) has been deemed terminated. The offering of these shares by selling securityholders will now proceed under the new Shelf Registration Statement pursuant to Section 415(a)(6) of the Securities Act.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies. The disclosure is strictly procedural regarding the transition of the resale registration mechanism for shares issued in a private placement completed on June 2, 2025.
Key Facts for Investor Verification
- Verify the effective date of the new Shelf Registration Statement (Form S-3, File No. 333-291239) as November 22, 2025.
- Confirm that the resale of 9,321,545 shares previously registered under Form S-1 is now governed by the new Shelf Registration Statement.
- Note that the information in Item 7.01 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
- Check subsequent filings for any actual sales of shares under the new Shelf Registration Statement.